These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 11813931

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparative efficacy of clarithromycin modified-release and clarithromycin immediate-release formulations in the treatment of lower respiratory tract infection.
    Adam D, Glaser-Caldow E, Wachter J, Brueckner OJ, Hein J, Kroemer B, Hirsch J.
    Clin Ther; 2001 Apr; 23(4):585-95. PubMed ID: 11354392
    [Abstract] [Full Text] [Related]

  • 3. Clarithromycin extended-release tablet: a review of its use in the management of respiratory tract infections.
    Darkes MJ, Perry CM.
    Am J Respir Med; 2003 Apr; 2(2):175-201. PubMed ID: 14720016
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A prospective, double-blind, multicenter study comparing clarithromycin extended-release with trovafloxacin in patients with community-acquired pneumonia.
    Sokol WN, Sullivan JG, Acampora MD, Busman TA, Notario GF.
    Clin Ther; 2002 Apr; 24(4):605-15. PubMed ID: 12017405
    [Abstract] [Full Text] [Related]

  • 6. Phase III, randomized, double-blind study of clarithromycin extended-release and immediate-release formulations in the treatment of adult patients with acute maxillary sinusitis.
    Murray JJ, Solomon E, McCluskey D, Zhang J, Palmer R, Notario G.
    Clin Ther; 2000 Dec; 22(12):1421-32. PubMed ID: 11192134
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Once daily clarithromycin extended-release vs twice-daily amoxicillin/clavulanate in patients with acute bacterial sinusitis: a randomized, investigator-blinded study.
    Riffer E, Spiller J, Palmer R, Shortridge V, Busman TA, Valdes J.
    Curr Med Res Opin; 2005 Jan; 21(1):61-70. PubMed ID: 15881476
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics and tolerability of extended-release clarithromycin.
    Guay DR, Gustavson LE, Devcich KJ, Zhang J, Cao G, Olson CA.
    Clin Ther; 2001 Apr; 23(4):566-77. PubMed ID: 11354390
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Generic versus non-generic formulation of extended-release clarithromycin in patients with community-acquired respiratory tract infections: a prospective, randomized, comparative, investigator-blind, multicentre study.
    Snyman JR, Schoeman HS, Grobusch MP, Henning M, Rabie W, Hira M, Parshotam K, Mithal Y, Singh S, Ramdas Z.
    Clin Drug Investig; 2009 Apr; 29(4):265-74. PubMed ID: 19301940
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of clarithromycin compared to cefixime as outpatient treatment of lower respiratory tract infections.
    Neu HC, Chick TW.
    Chest; 1993 Nov; 104(5):1393-9. PubMed ID: 8222794
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.